Glucose transport: Pivotal step in insulin action

Diabetes

Volumn 45, Issue 11, 1996, Pages 1644-1654

  Kahn, Barbara B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; GLUCOSE; GLUCOSE TRANSPORTER 4; MUSCLE PROTEIN; SLC2A4 PROTEIN, HUMAN; SLC2A4 PROTEIN, MOUSE;

CONFERENCE PAPER; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEMBRANE TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; DIABETES MELLITUS; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MODELS, BIOLOGICAL; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY;

EID: 0030292743     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1644     Document Type: Conference Paper

References (64)

1. Simpson IA, Cushman SW: Hormonal regulation of mammalian glucose transport. Annu Rev Biochem 55:1059-1089, 1989
2. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S: Molecular biology of mammalian glucose transporters. Diabetes Care 13:198-208, 1990
3. Mueckler M: Family of glucose-transporter genes: implications for glucose homeostasis and diabetes. Diabetes 39:6-11, 1990
4. Waddell ID, Zomerschoe AG, Voice MW, Burchell A: Cloning and expression of a hepatic microsomal glucose transporter protein. Biochem J 286:173-177, 1992
5. DeFronzo RA: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-684, 1988
6. Rothman DL, Shulman RG, Shulman GI: 31 P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1069-1075, 1982
7. Butler PC, Kryshak EJ, Marsh M, Rizza RA: Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM: evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes 39:1373-1380, 1990
8. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA: Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes 39:157-167, 1990
9. Karnieli E, Zarnowski MJ, Hissin PJ, Simpson LA, Salans LB, Cushman SW: Insulin-stimulated translocation of glucose transport systems in the rat adipose cell: time course, reversal, insulin concentration-dependency and relationship to glucose transport activity. J Biol Chem 256:4772-4777, 1981
10. Holman G, Leggio L, Cushman S: Insulin-stimulated GLUT4 transporter recycling: a problem in membrane protein subcellular trafficking through multiple pools. J Biol Chem 269:17516-17524, 1994
11. Abel ED, Shepherd PR, Kahn BB: Glucose transporters and pathophysiologic states. In Diabetes Mellitus: A Fundamental and Clinical Text. DR LeRoith, JM Olefsky, SI Taylor, Eds. Philadelphia, Lippincott, 1996, p. 530-543
12. Kahn BB, Charron MJ, Lodish HF, Cushman SW, Flier JS: Differential regulation of two glucose transporters in adipose cells from diabetic and insulin treated diabetic rats. J Clin Invest 84:404-411, 1989
13. Kahn BB, Horton ES, Cushman SW: Mechanisms for enhanced glucose transport response to insulin in adipose cells from chronically hyperin- sulinemic rats: increased translocation of glucose transporters from an enlarged intracellular pool. J Clin Invest 79:853-858, 1987
14. Kolterman OG, Insel J, Saekow M, Olefsky JM: Mechanisms of insulin resistance in human obesity. J Clin Invest 65:1272-1284, 1980
15. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
16. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L: Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest 87:561-570, 1991
17. DeFronzo RA, Jacto E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose. Diabetes 30:1000-1007, 1981
18. Kahn BB, Rossetti L, Lodish HF, Charron MJ: Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest 87:2197-2206, 1991
19. Ramlal T, Rastogi S, Vranic M, Klip A: Decrease in glucose transporter number in skeletal muscle of mildly diabetic (streptozotocin-treated) rats. Endocrinology 125:890-897, 1989
20. Napoli R, Hirshman MF, Horton ES: Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. J Clin Invest 96:427-437, 1995
21. Youn J, Kim J, Buchanan T: Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection. Diabetes 43:564-571, 1994
22. Richardson JM, Balon TW, Treadway JL, Pessin JE: Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266:12690-12694, 1991
23. Zierath JR, Houseknecht KL, Kahn BB: Glucose transporters and diabetes. In Seminars in Cell and Developmental Biology 7:295-307, 1996
24. Lowell BB, Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-742, 1993
25. Hamann A, Benecke H, LeMarchand-Brustel Y, Susulic VS, Lowell BB, Flier JS: Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266-1273, 1995
26. Frevert ED, Hamann A, Lowell BB, Flier JS, Kahn BB: Decreased insulin action precedes down regulation of Glut4 in adipocytes in a novel transgenic model of obesity and NIDDM (Abstract). Diabetes 44 (Suppl. 1):38A, 1995
27. Stern JS, Johnson PR, Batchelor BR, Zucker LM, Hirsh J: Pancreatic insulin release and peripheral tissue resistance in Zucker obese rats fed high and low carbohydrate diets. Am J Physiol 228:543-548, 1975
28. Hainault I, Guerre-Millo M, Guichard C, Lavau M: Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). J Clin Invest 87:1127-1131, 1991
29. Pedersen O, Kahn CR, Kahn BB: Divergent regulation of the GLUT1 and GLUT4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 89:1964-1973, 1992
30. Kahn BB, Pedersen O: Suppression of GLUT4 expression in skeletal muscle of rats which are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology 132:13-22, 1993
31. Kahn BB: Facultative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 89:1367-1374, 1992
32. King PA, Horton ED, Hirshman MF, Horton ES: Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest 90:1568-1575, 1992
33. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD: Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (Glut4). J Clin Invest 95:1512-1518, 1995
34. Rosholt MN, King PA, Horton ES: High fat diet reduces glucose transporter response to insulin. Am J Physiol 266:R95-R101, 1994
35. 34a. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB: High fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin signaling defect. Diabetes. In press
36. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB: Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865-870, 1990
37. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41:465-475, 1992
38. Kahn BB, Rosen AS, Bak JF, Andersen PH, Lund S, Pedersen O: Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. J Clin Endocrinol Metab 74:1101-1109, 1992
39. Garvey WT: Glucose transport and NIDDM. Diabetes Care 15:396-417, 1992
40. Sinha MK, Raineri-Maldonado C, Buchanan C, Pories WJ, Carter-Su C, Pilch PF, Caro JO: Adipose tissue glucose transporters in NIDDM. Diabetes 40:472-477, 1991
41. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, Fisher EC, Wolfe RR, Elahi D, Evans WJ: Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264:E855-E862, 1993
42. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr.: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147-152, 1991
43. Elahi D, McAloon-Dyke M, Clark BA, Kahn BB, Weinreb JE, Minaker KL, Wong G, Morse L, Brown R, Shapiro M, Gingerich R, Rosenlof L, Pruett T, Andersen DK, Hanks JB: Sequential evaluation of islet cell responses to glucose in the human transplanted pancreas: a one year follow-up study. Am J Surg 165:15-22, 1993
44. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB: Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243-22246, 1993
45. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu H-L, Mellovitz B, Spiegelman BM: A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci USA 87:9590-9594, 1990
46. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P: Glucose uptake in human adipose tissue. Metabolism 36:1154-1160, 1987
47. Houseknecht KL, Martin S, Keller SR, James DE, Kahn BB: Overexpression of Glut4 in adipocytes of transgenic mice saturates sorting (Abstract). Diabetes 45:156A, 1996
48. Tozzo E, Shepherd PR, Gnudi L, Kahn BB: Transgenic GLUT4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis. An J Physiol 268:E956-E964, 1995
49. Tozzo E, Gnudi L, Bliss JL, Kahn BB: Overexpression of GLUT4 driven by a heterologous promoter is maintained in streptozotocin diabetic mice and prevents insulin resistance in isolated adipocytes (Abstract). Diabetes 43 (Suppl. 1):14A, 1994
50. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ: Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45:28-36, 1996
51. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J: Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45:23-27, 1996
52. Cheatham B, Kahn RC: Insulin action and the insulin signaling network. Endocrine Rev 16:117-142, 1995
53. Abel ED, Houseknecht KL, Kahn BB: Recent advances in understanding the molecular basis for insulin stimulated glucose transport. Curr Opin Endocrinol Diabetes 2:313-324, 1995
54. Houseknecht KL, Zhu AX, Gnudi L, Hamann A, Zierath JR, Flier JS, Kahn BB: Overexpression of H-Ras selectively in adipose tissue of transgenic mice: evidence for enhanced sensitivity to insulin. J Biol Chem 271:11347-11355, 1996
55. Hausdorff SF, Frangioni JV, Birnbaum MJ: Role of p21ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes. J Biol Chem 269:21391-21394, 1994
56. Quon MJ, Chen H, Ing BL, Liu ML, Zarnowski MJ, Yonezawa K, Kasuga M, Cushman SW, Taylor SI: Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cell Biol 15:5403-5411, 1995
57. Reusch JE, Bhuripanyo P, Carel K, Leitner JW, Hsieh P, DePaolo D, Draznin B: Differential requirement for p21ras activation in the metabolic signaling by insulin. J Biol Chem 270:2036-2040, 1995
58. Manchester J, Kong X, Lowry OH, Lawrence JC Jr: Ras signaling in the activation of glucose transport by insulin. Proc Natl Acad Sci USA 91:4644-4648, 1994
59. Gnudi L, Zhu AX, Hamann A, Houseknecht KL, Flier JS, Kahn BB: Obesity and divergent effects on insulin signaling in transgenic mice expressing a dominant negative mutant ras (Abstract). Diabetes 44 (Suppl. 1):20A, 1895
60. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT: Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol- 3 kinase. Science 268:100, 1995
61. Viciana-Rodriguez P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J: Phosphatidylinositol-3-OH kinase as a direct target of ras. Nature 370:527-532, 1994
62. Cheatham B, Vlahos C, Cheatham L, Wang L, Blenis J, Kahn CE: Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911, 1994
63. Clarke J, Young P, Yonezawa K, Kasuga M, Holman G: Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 300:631-635, 1994
64. Dohm GL, Elton CW, Friedman JE, Pilch PF, Pories WJ Jr, Atkinson SM, Caro JF: Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol 260:E459-E463, 1991